SAGITTABIOTECH.COM KEYWORD DENSITY CHECKER

Total words: 2365 | 2-word phrases: 625 | 3-word phrases: 689 | 4-word phrases: 709

PAGE INFO

Title Try to keep the title under 60 characters (74 characters)
Innovative viral vectors for vaccines, oncology and gene therapy - Sagitta
Description Try to keep the meta description between 50 - 160 characters (431 characters)
Sagitta Biotech is a company developing an innovative viral vector to develop efficient vaccines, oncolytic viruses and gene therapy vectors.Our active virosome platform can deliver up to 17kb mRNA (6 genes), and elicit both humoral and cellular response.Sagitta is developing its own pipeline of innovative multivalent vaccines (currently in preclinical phases) and oncolytic viruses, and is open to partnering and co-development.
Keywords Meta keywords are not recommended anymore (0 characters)
H1 H1 tag on the page (92 characters)
Innovative active virosomes to tackle unmet medical needs in infectious disease and oncology

ONE WORD PHRASES 342 Words

# Keyword H1 Title Des Volume Position Suggest Frequency Density
1to4011.70%
2the277.89%
3and257.31%
4on226.43%
5or205.85%
6a185.26%
7is154.39%
8in133.80%
9of133.80%
10for133.80%

TWO WORD PHRASES 625 Words

# Keyword H1 Title Des Volume Position Suggest Frequency Density
1active virosome60.96%
2up to60.96%
3sagitta biotech60.96%
4or access60.96%
5can be60.96%
6target cell60.96%
7technical storage50.80%
8storage or50.80%
9the vector50.80%
10on the50.80%
11out more40.64%
12it is40.64%
13to find40.64%
14touch to40.64%
15in touch40.64%
16to be40.64%
17surface to40.64%
18genes can40.64%
19find out40.64%
20expressed on40.64%

THREE WORD PHRASES 689 Words

# Keyword H1 Title Des Volume Position Suggest Frequency Density
1storage or access50.73%
2technical storage or50.73%
3find out more40.58%
4to find out40.58%
5touch to find40.58%
6in touch to40.58%
7genes can be40.58%
8up to 17kb30.44%
9get in touch30.44%
10up to 630.44%
11or access is30.44%
12vector surface to30.44%
13on the vector30.44%
14a cd4cd8 response20.29%
15what is active20.29%
16more what is20.29%
17and a humoral20.29%
18response through the20.29%
19both a cd4cd820.29%
20sagitta biotech is20.29%
21inducing both a20.29%
22biotech is developing20.29%
23is developing an20.29%
24developing an active20.29%
25an active virosome20.29%
26thereby inducing both20.29%
27cell thereby inducing20.29%
28technology based on20.29%
29based on a20.29%
30on a highlymodified20.29%

FOUR WORD PHRASES 709 Words

# Keyword H1 Title Des Volume Position Suggest Frequency Density
1technical storage or access50.71%
2in touch to find40.56%
3touch to find out40.56%
4to find out more40.56%
5get in touch to30.42%
6storage or access is30.42%
7nonreplicating and to display20.28%
8and to display no20.28%
9be expressed on the20.28%
10to display no measles20.28%
11to be nonreplicating and20.28%
12is used exclusively for20.28%
13that is used exclusively20.28%
14access that is used20.28%
15or access that is20.28%
16storage or access that20.28%
17response through the mhci20.28%
18be nonreplicating and to20.28%
19target cogs below 1dose20.28%
20display no measles surface20.28%
21measles virus it is20.28%
22capex target cogs below20.28%
23low capex target cogs20.28%
24processes low capex target20.28%
25measles processes low capex20.28%
26on measles processes low20.28%
27manufacturing on measles processes20.28%
28antigens this makes it20.28%
29viruses quickly costeffective largescale20.28%
30oncolytic viruses quickly costeffective20.28%
31vaccinescomplex oncolytic viruses quickly20.28%
32this makes it safe20.28%
33makes it safe and20.28%
34it safe and effective20.28%
35virus it is specifically20.28%
36a highlymodified measles virus20.28%
37highlymodified measles virus it20.28%
38the subscriber or user20.28%
39receptors on the vector20.28%
40on the vector surface20.28%

EXTERNAL LINKS

# URL Whois Check
1https://cookiedatabase.org/tcf/purposes/ Whoiscookiedatabase.org